• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Roche warns of software issues for its diabetes care platform

June 6, 2024 By Sean Whooley

Roche logo - updatedRoche Diabetes Care notified customers of a software bug that could lead to patient data mismatches on its RocheDiabetes Care platform.

The RocheDiabetes Care platform offers a browser-based solution for visualizing and analyzing relevant therapy information. That could include glucose values, insulin, nutrition and activity data, helping to make treatment decisions for patients with diabetes.

However, Roche says that it identified a potential issue with the release of the V2.10.1 software on April 27, 2024. It found the potential for patient data mismatch to happen from one patient displayed in the profile of another patient as the need to refresh the page was not prompted and previously rendered patient data were displayed.

Physicians may not have immediately been able to detect the issue, which could lead to an inappropriate therapy recommendation. Potential consequences could particularly affect those on insulin therapy. Those consequences could include severe hypoglycemia.

The company issued a bug fix through a cloud-based software update (v2.10.3) on May 14. Since the company resolved the issue via the cloud, the notice requires no action from customers themselves to address it. They have access to the latest software version whenever they log into the RocheDiabetes Care platform.

“At Roche Diabetes Care, our utmost priority is ensuring the highest quality of our products and services. We are committed to keeping you well-informed about any potential issues that may arise,” the company’s notice says.

Filed Under: Diabetes, Featured, Regulatory/Compliance, Technology Tagged With: Roche, Roche Diabetes Care

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS